Pharma Orders Up in Honyaku’s Core Translation Business; All Other Sectors Decline
Sales in Honyaku Center’s core translation business continue to decline, down 9.5% to USD 50m for 9 months to December 2020, but pharma orders up 2.4% to USD 20m. FY 2020 forecast upgraded to USD 91m.
Your information will not be shared with third parties. No Spam.